Literature DB >> 7622246

Functional domains of Pseudomonas aeruginosa exoenzyme S.

D A Knight1, V Finck-Barbançon, S M Kulich, J T Barbieri.   

Abstract

Recombinant exoenzyme S (rHisExoS) of Pseudomonas aeruginosa was expressed in Escherichia coli as a soluble, cytosolic His fusion protein. rHisExoS was purified by Ni(2+)-affinity chromatography in the presence of protease inhibitors without detectable degradation. rHisExoS possessed a specific activity (within twofold) for the factor-activating exoenzyme S-dependent ADP-ribosylation of soybean trypsin inhibitor (SBTI) similar to that of native exoenzyme S. Analysis of several deletion peptides showed that delta N222, which encoded the carboxyl-terminal 222 amino acids of exoenzyme S, possessed factor-activating exoenzyme S-dependent ADP-ribosyltransferase activity. delta N222 catalyzed the ADP-ribosylation of SBTI at a rate sixfold greater than rHisExoS. Relative to rHisExoS, delta N222 had a similar affinity for NAD, a threefold greater affinity for SBTI, and a four- to eightfold greater kcat for the ADP-ribosylation of SBTI. Like native exoenzyme S, rHisExoS chromatographed as an aggregate with an apparent molecular mass of > 300 kDa. In contrast, delta N222 did not chromatograph as an aggregate, which showed that the amino-terminal 99 amino acids of exoenzyme S were responsible for the aggregation phenotype.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7622246      PMCID: PMC173434          DOI: 10.1128/iai.63.8.3182-3186.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Mechanism of activation of cholera toxin by ADP-ribosylation factor (ARF): both low- and high-affinity interactions of ARF with guanine nucleotides promote toxin activation.

Authors:  D A Bobak; M M Bliziotes; M Noda; S C Tsai; R Adamik; J Moss
Journal:  Biochemistry       Date:  1990-01-30       Impact factor: 3.162

2.  Mechanism of cholera toxin activation by a guanine nucleotide-dependent 19 kDa protein.

Authors:  M Noda; S C Tsai; R Adamik; J Moss; M Vaughan
Journal:  Biochim Biophys Acta       Date:  1990-05-16

Review 3.  Diphtheria toxin: mode of action and structure.

Authors:  R J Collier
Journal:  Bacteriol Rev       Date:  1975-03

4.  ADP-ribosylation of p21ras and related proteins by Pseudomonas aeruginosa exoenzyme S.

Authors:  J Coburn; D M Gill
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

5.  The role of exoenzyme S in infections with Pseudomonas aeruginosa.

Authors:  T I Nicas; J Bradley; J E Lochner; B H Iglewski
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

6.  Several GTP-binding proteins, including p21c-H-ras, are preferred substrates of Pseudomonas aeruginosa exoenzyme S.

Authors:  J Coburn; R T Wyatt; B H Iglewski; D M Gill
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

7.  Exoenzyme S of Pseudomonas aeruginosa ADP-ribosylates the intermediate filament protein vimentin.

Authors:  J Coburn; S T Dillon; B H Iglewski; D M Gill
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

8.  Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S.

Authors:  T I Nicas; B H Iglewski
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

9.  Contribution of exoenzyme S to the virulence of Pseudomonas aeruginosa.

Authors:  T I Nicas; B H Iglewski
Journal:  Antibiot Chemother (1971)       Date:  1985

10.  Pseudomonas aeruginosa exotoxin A: alterations of biological and biochemical properties resulting from mutation of glutamic acid 553 to aspartic acid.

Authors:  C M Douglas; R J Collier
Journal:  Biochemistry       Date:  1990-05-29       Impact factor: 3.321

View more
  30 in total

1.  Differential sensitivity of human epithelial cells to Pseudomonas aeruginosa exoenzyme S.

Authors:  E M McGuffie; J E Fraylick; D J Hazen-Martin; T S Vincent; J C Olson
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

2.  Ras effector pathway activation by epidermal growth factor is inhibited in vivo by exoenzyme S ADP-ribosylation of Ras.

Authors:  M L Henriksson; R Rosqvist; M Telepnev; H Wolf-Watz; B Hallberg
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

3.  Pseudomonas aeruginosa exoenzyme S is a biglutamic acid ADP-ribosyltransferase.

Authors:  J Radke; K J Pederson; J T Barbieri
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

4.  Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein.

Authors:  R Krall; G Schmidt; K Aktories; J T Barbieri
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  Examination of the coordinate effects of Pseudomonas aeruginosa ExoS on Rac1.

Authors:  Claudia L Rocha; Elizabeth A Rucks; Deanne M Vincent; Joan C Olson
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

6.  Pseudomonas aeruginosa exoenzyme S stimulates murine lymphocyte proliferation in vitro.

Authors:  N G Barclay; J C Spurrell; T F Bruno; D G Storey; D E Woods; C H Mody
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

7.  Biochemical relationships between the 53-kilodalton (Exo53) and 49-kilodalton (ExoS) forms of exoenzyme S of Pseudomonas aeruginosa.

Authors:  S Liu; T L Yahr; D W Frank; J T Barbieri
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

8.  Characterization of an ADP-ribosyltransferase toxin (AexT) from Aeromonas salmonicida subsp. salmonicida.

Authors:  Martin Braun; Katja Stuber; Yvonne Schlatter; Thomas Wahli; Peter Kuhnert; Joachim Frey
Journal:  J Bacteriol       Date:  2002-04       Impact factor: 3.490

9.  Identification and characterization of SpcU, a chaperone required for efficient secretion of the ExoU cytotoxin.

Authors:  V Finck-Barbançon; T L Yahr; D W Frank
Journal:  J Bacteriol       Date:  1998-12       Impact factor: 3.490

10.  Characterization of Pseudomonas aeruginosa exoenzyme S as a bifunctional enzyme in J774A.1 macrophages.

Authors:  Claudia L Rocha; Jenifer Coburn; Elizabeth A Rucks; Joan C Olson
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.